Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities:
Net increase (decrease) in net assets resulting from operations	$ 19,741,835	$ 29,789,927	$ 16,159,975
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gains)/losses on investments	6,703,118	(781,864)	(839,046)
Net change in unrealized (appreciation) depreciation on investments	4,511,639	3,036,660	5,604,979
Net accretion of discount on investments	(2,051,562)	(1,850,417)	(1,451,317)
Amortization of deferred financing costs	974,490	1,111,667	834,681
Amortization of deferred offering costs			95,093
Payment-in-kind interest income	(2,532,202)	(1,556,095)	(1,878,423)
Purchases and drawdowns of investments	(209,662,485)	(108,266,876)	(338,843,134)
Sales and repayments of investments	218,187,175	81,295,385	73,264,521
(Increase) decrease in operating assets:
Interest and other receivables	(4,014,232)	5,893,201	(8,279,813)
Receivable for investments sold	(7,990,278)
Prepaid expenses	(43,667)	(47,315)	(16,367)
Increase (decrease) in operating liabilities:
Management fee payable	(34,331)	(764,716)	868,030
Incentive fee payable	76,777	(765,126)	1,725,588
Administration fee payable	144,556	(389,980)	(709,664)
Interest payable	401,583	1,987,328	1,512,453
Payable for investments purchased	31,286,337	8,100,000	(14,893,750)
Accrued expenses and other liabilities	2,648,422	334,130	356,347
Net cash provided by (used in) operating activities	58,347,175	17,125,909	(266,489,847)
Cash Flows from Financing Activities:
Proceeds from issuance of common shares	41,391,335	18,178,008	103,419,659
Redemption of common shares	(45,794,531)	(68,165,852)
Distributions to shareholders	(25,532,887)	(13,013,553)	(8,298,397)
Borrowings on credit facility	112,800,000	81,500,000	304,000,000
Payments on credit facility	(126,800,000)	(29,500,000)	(210,000,000)
Financing costs paid	(2,667,500)		(1,576,980)
Net cash provided by (used in) financing activities	(46,603,583)	(11,001,397)	187,544,282
Net increase (decrease) in cash and cash equivalents	11,743,592	6,124,512	(78,945,565)
Cash and cash equivalents and restricted cash, beginning of period	12,555,591	6,431,079	85,376,644
Cash and cash equivalents and restricted cash, end of period	24,299,183	12,555,591	6,431,079
Supplemental and Non-Cash Information
Cash paid for interest	19,153,654	17,523,955	4,573,527
Reinvestments of distributions	4,211,092	19,054,731	13,342,557
Reconciliation of Cash and Cash Equivalents and Restricted Cash
Cash and cash equivalents	23,631,682	9,813,406	6,395,756
Restricted cash	667,501	2,742,185	35,323
Total cash and cash equivalents and restricted cash	$ 24,299,183	$ 12,555,591	$ 6,431,079